One Platform. Multiple Applications.
Kihealth's molecular diagnostic platform is designed to generate actionable biological insights across prevention, clinical care, therapeutic development, and population health.
A platform connecting every stakeholder in metabolic health
Patients, physicians, researchers, pharmaceutical companies, clinical trials, employers, and health systems — all served by a single molecular intelligence layer purpose-built for metabolic disease.
Population Screening & Early Detection
Identifying disease risk before symptoms emerge.
Traditional testing often identifies disease after years of progression. Kihealth is designed to provide insight into biological processes occurring earlier in the disease continuum.
- Population health programs
- Employer screening initiatives
- Wellness programs
- Preventative healthcare
- Risk stratification
- Community screening initiatives
The greatest healthcare opportunity may be identifying disease before irreversible damage occurs.
Clinical Decision Support
Providing physicians with deeper biological insight.
Equipping physicians with molecular-level signals that complement clinical judgment — supporting earlier intervention and more individualized management plans.
- Metabolic risk assessment
- Disease progression monitoring
- Longitudinal patient management
- Early intervention programs
- Precision medicine initiatives
Better biological information can support more informed clinical decisions.
Clinical Trial Stratification
Helping identify the right patients for the right studies.
One of the largest challenges in therapeutic development is identifying appropriate patient populations. Molecular stratification can sharpen enrollment, improve study power, and accelerate timelines.
- Patient selection
- Risk-based enrollment
- Biomarker-guided recruitment
- Precision trial design
- Endpoint development
Therapeutic Development & Innovation
Supporting the next generation of metabolic therapeutics.
As therapeutic innovation accelerates, diagnostics become increasingly important for identifying patients, measuring outcomes, and supporting precision medicine across the development lifecycle.
- Companion diagnostics
- Patient identification
- Therapeutic monitoring
- Biomarker endpoints
- Treatment optimization
Advanced therapeutics require advanced diagnostics.
GLP-1 & Metabolic Therapy Monitoring
Measuring biological response beyond weight loss alone.
As the global GLP-1 market expands, healthcare providers and pharmaceutical companies will increasingly require objective methods for monitoring biological response and metabolic health beyond weight as a surrogate.
- Therapy initiation
- Response monitoring
- Risk assessment
- Treatment optimization
- Long-term outcome tracking
Disease Progression Monitoring
Understanding how biology changes over time.
Longitudinal monitoring enables healthcare providers and researchers to evaluate biological trends rather than relying solely on isolated measurements.
- Disease monitoring
- Risk tracking
- Lifestyle intervention programs
- Therapeutic monitoring
- Population health management
Employer & Population Health Programs
Helping organizations build healthier populations.
Metabolic disease is one of the largest drivers of employer healthcare spend. Early identification and intervention shift the curve from chronic management to durable prevention.
- Employer wellness programs
- Corporate health initiatives
- Health plan partnerships
- Population health management
- Preventative care strategies
Earlier identification of risk has the potential to improve outcomes while reducing long-term healthcare costs.
Academic Research & Scientific Discovery
Advancing the understanding of metabolic disease.
Partnering with universities, academic medical centers, and translational research groups to deepen the biological understanding of metabolic disease and validate new biomarkers.
- Academic collaborations
- Investigator-initiated studies
- Translational medicine
- Biomarker validation
- Disease biology research
Building the Infrastructure for Metabolic Intelligence
The future of healthcare will require more than diagnostics alone. It will require platforms capable of generating actionable biological intelligence across prevention, treatment, research, and therapeutic innovation.
Kihealth Europe is building that foundation.